Millennium Management’s Kezar Life Sciences KZR Stock Holding History

Millennium Management’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.05M	Buy	+142,050	New	+$924K	﹤0.01%	4354
2025 Q3	–	Sell	-25,677	Closed	-$118K	–	6271
2025 Q2	$118K	Sell	25,677 -5,703	-18%	-$24.4K	﹤0.01%	5493
2025 Q1	$153K	Sell	31,380 -11,957	-28%	-$72.6K	﹤0.01%	5357
2024 Q4	$291K	Sell	43,337 -6,086	-12%	-$45.3K	﹤0.01%	5086
2024 Q3	$382K	Sell	49,423 -13,428	-21%	-$81K	﹤0.01%	5034
2024 Q2	$377K	Sell	62,851 -18,846	-23%	-$143K	﹤0.01%	4775
2024 Q1	$737K	Sell	81,697 -211,059	-72%	-$1.92M	﹤0.01%	4546
2023 Q4	$2.77M	Sell	292,756 -47,455	-14%	-$417K	﹤0.01%	3325
2023 Q3	$4.05M	Sell	340,211 -33,900	-9%	-$601K	﹤0.01%	2898
2023 Q2	$9.17M	Buy	374,111 +120,401	+47%	+$3.13M	﹤0.01%	2108
2023 Q1	$7.94M	Sell	253,710 -35,940	-12%	-$2.08M	﹤0.01%	2186
2022 Q4	$20.4M	Sell	289,650 -6,577	-2%	-$488K	0.01%	1433
2022 Q3	$25.5M	Buy	296,227 +21,332	+8%	+$2.07M	0.02%	1125
2022 Q2	$22.7M	Buy	274,895 +182,689	+198%	+$16.1M	0.01%	1190
2022 Q1	$15.3M	Buy	92,206 +53,142	+136%	+$7.63M	0.01%	1661
2021 Q4	$6.53M	Buy	39,064 +37,736	+2,842%	+$4.26M	﹤0.01%	2624
2021 Q3	$115K	Sell	1,328 -78,808	-98%	-$5.22M	﹤0.01%	6376
2021 Q2	$4.35M	Buy	80,136 +2,108	+3%	+$120K	﹤0.01%	2937
2021 Q1	$4.65M	Sell	78,028 -14,588	-16%	-$853K	﹤0.01%	2650
2020 Q4	$4.83M	Buy	92,616 +27,503	+42%	+$1.53M	﹤0.01%	2476
2020 Q3	$3.15K	Sell	65,113 -20,775	-24%	-$994K	﹤0.01%	2231
2020 Q2	$4.45M	Buy	85,888 +72,719	+552%	+$3.67M	0.01%	1883
2020 Q1	$574K	Buy	13,169 +10,868	+472%	+$442K	﹤0.01%	2800
2019 Q4	$92K	Buy	2,301 +795	+53%	+$24.5K	﹤0.01%	4039
2019 Q3	$49K	Sell	1,506 -4,716	-76%	-$228K	﹤0.01%	4046
2019 Q2	$480K	Buy	+6,222	New	+$968K	﹤0.01%	3266
2018 Q4	–	Sell	-5,463	Closed	-$1.17M	–	3969
2018 Q3	$1.17M	Sell	5,463 -2,052	-27%	-$358K	﹤0.01%	2784
2018 Q2	$1.3M	Buy	+7,515	New	+$1.31M	﹤0.01%	2678

Other funds holding KZR

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Millennium Management's KZR Position: Q1 2026 in Review

Millennium Management opened a new position in Kezar Life Sciences (KZR) in Q1 2026: 142,050 shares worth $1.05M. The stake represents ﹤0.01% of the portfolio and ranks #4354 among its holdings. This is a return to the name: Millennium Management previously reported a position in KZR as recently as Q2 2025.

Millennium Management first reported a position in KZR in Q2 2018 and has held it in 28 quarters since. The position peaked at $25.5M in Q3 2022. 43 funds tracked by Wall St. Rank hold KZR as of Q1 2026.

Millennium Management held 142,050 shares of Kezar Life Sciences worth $1.05M as of Q1 2026.
Kezar Life Sciences was a new Millennium Management position in Q1 2026.
Kezar Life Sciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4354 holding.
Millennium Management first reported a position in Kezar Life Sciences in Q2 2018 and has held it in 28 quarters since.
Millennium Management's Kezar Life Sciences position peaked at $25.5M in Q3 2022.
43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.